Literature DB >> 27557372

Utilization of hospital services for cancer care in Mexico.

Juan Eugenio Hernández-Ávila, Lina Sofía Palacio-Mejía, Leonel González-González, Evangelina Morales-Carmona, Lucino Iván Espín-Arellano, Julián Alfredo Fernández-Niño, Alejandro Mohar-Betancourt, Mauricio Hernández-Ávila.   

Abstract

OBJECTIVE: To analyze the utilization of hospital services for cancer care by location, sex, age group and care institution in Mexico from 2004-2013.
MATERIALS AND METHODS: Time series study from 2004-2013, based on administrative records of hospital discharges for cancer in the health sector, including the private sector.
RESULTS: The utilization rate increased significantly from 290 to 360 per 100 000 inhabitants. A total of 62% of hospital discharges related to malignant tumors were concentrated in eight types of cancer. Leukemia, breast and colorectal cancers almost doubled in the period. While lung cancer showed a decline among men, it increased among women. A total of 63.1% of cancer patients were women, and 81% of cases occurred in the public sector. From 2011, the Ministry of Health was the main provider of hospital services for cancer care.
CONCLUSIONS: Increases in utilization were mainly found in the Ministry of Health, quite possibly as a result of the implementation of universal insurance.

Entities:  

Mesh:

Year:  2016        PMID: 27557372     DOI: 10.21149/spm.v58i2.7783

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  3 in total

1.  Access to innovative cancer medicines in a middle-income country - the case of Mexico.

Authors:  Daniela Moye-Holz; Rene Soria Saucedo; Jitse P van Dijk; Sijmen A Reijneveld; Hans V Hogerzeil
Journal:  J Pharm Policy Pract       Date:  2018-10-24

2.  Psychometric validation of a Patient-Centred Quality of Cancer Care Questionnaire in Mexico.

Authors:  Svetlana V Doubova; Ingrid Patricia Martinez-Vega; Marcos Gutiérrez-De-la-Barrera; Claudia Infante-Castañeda; Carlos E Aranda-Flores; Adriana Monroy; Laura Gómez-Laguna; Felicia Marie Knaul; Ricardo Pérez-Cuevas
Journal:  BMJ Open       Date:  2020-03-16       Impact factor: 2.692

3.  Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.

Authors:  Daniela Moye-Holz; Margaret Ewen; Anahi Dreser; Sergio Bautista-Arredondo; Rene Soria-Saucedo; Jitse P van Dijk; Sijmen A Reijneveld; Hans V Hogerzeil
Journal:  BMC Health Serv Res       Date:  2020-05-14       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.